Last update 21 Nov 2024
RSS0393
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Chemical drugs |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  Reistone Biopharma Co. Ltd.Startup |
Active Organization Reistone Biopharma Co. Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with RSS0393一项在健康人和银屑病成年受试者中评价RSS0393软膏单次和多次剂量递增局部皮肤给药的安全性和药代动力学特征的随机、双盲、安慰剂对照的I期临床试验
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical trial to evaluate the safety and pharmacokinetic characteristics of single and multiple ascending doses of RSS0393 ointment in healthy subjects and adult subjects with psoriasis
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Pharmacokinetic Profile of RSS0393 Ointment as a Single and Multiple Dose Ascending Local Dermal Administration in Healthy and Adult Subjects With Psoriasis
100 Clinical Results associated with RSS0393
Login to view more data
100 Translational Medicine associated with RSS0393
Login to view more data
100 Patents (Medical) associated with RSS0393
Login to view more data
100 Deals associated with RSS0393
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Psoriasis | Phase 1 | CN | Reistone Biopharma Co. Ltd.Startup | 01 Mar 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free